• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Chemed Corp

    6/27/25 10:00:20 AM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email
    11-K 1 che-20241231x11k.htm 11-K 20241231 11K

    

    UNITED STATES

    

    SECURITIES AND EXCHANGE COMMISSION

    

    Washington, D.C. 20549

    

    FORM 11-K

    

    For Annual Reports of Employee Stock Purchase, Savings and Similar Plans Pursuant to Section 15(d) of the Securities Exchange Act of 1934

    

    (Mark One)

    

    x

    Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024

    

    ¨

    Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351

    

    A:Full title of plan and the address of the plan, if different from that of the issuer named below:

    

    CHEMED/ROTO-ROOTER SAVINGS & RETIREMENT PLAN

    

    B:Name of the issuer of the securities held pursuant to the plan and address of its principal executive office:

    

    

    

    

    CHEMED CORPORATION

    

    255 E. Fifth Street, Suite 2600, Cincinnati, Ohio 45202

    (513) 762-6690

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    Page 1 of 3


     

    

    

    REQUIRED INFORMATION

    

    The Financial Statements and Supplemental Schedule for the Chemed/Roto-Rooter Savings and Retirement Plan identified below are being filed with this Annual Report on Form 11-K:

    

    

     

     

    ITEM 1. FINANCIAL STATEMENTS AND EXHIBITS

    PAGE NUMBER

    (a) Financial Statements

     

    1.

    Report of Independent Registered Public Accounting Firm

    F-S 1 

    2.

    Statements of Net Assets Available for Benefits at

    F-S 2

    

    December 31, 2024 and 2023

     

    3.

    Statement of Changes in Net Assets Available for Benefits

    F-S 3

    

    For the Year Ended December 31, 2024

     

    4.

    Notes to Financial Statements

    F-S 4 through F-S 10

    5.

    Schedule:

     

    

    Schedule I – Schedule of Assets (Held At End of Year)

    F-S 11

    6.

    Consent of Independent Registered Public Accounting Firm - 2024

    Exhibit I

    

     

     

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    Page 2 of 3

    


     

    SIGNATURES

    

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Administrative Committee of the Chemed/Roto-Rooter Savings and Retirement Plan has caused this annual report to be signed by the undersigned hereunto duly authorized.

    

    

    Dated: June 27,  2025CHEMED/ROTO-ROOTER SAVINGS & RETIREMENT PLAN

    

    

    By: /s/ Jeff Finke

    

    Jeff Finke

    

    Administrative Committee

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    Page 3 of 3

    

    

    

    

    


     

    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

    

    To the Plan Participants, Plan Administrator, and Investment Committee of

    the Chemed/Roto-Rooter Savings and Retirement Plan

    

    Opinion on the Financial Statements

    We have audited the accompanying statements of net assets available for benefits of the Chemed/Roto-Rooter Savings and Retirement Plan (the Plan) as of December 31, 2024 and 2023, and the related statement of changes in net assets available for benefits for the year ended December 31, 2024, and the related notes and schedule (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2024 and 2023, and the changes in net assets available for benefits for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

    

    Basis for Opinion

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    

    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

    

    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

    

    Supplemental Information

    The supplemental information contained in the schedule of assets held at end of year has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

    

    /s/ Clark, Schaefer, Hackett & Co.

    

    We have served as the Plan’s auditor since 2023.

    

    Cincinnati, Ohio

    June 27, 2025

    

    

    

    

    

    

    

    

    F-S 1

     


     

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Statements of Net Assets Available for Benefits

    

    

    

    

     

     

     

     

    

     

     

    

     

    December 31,

    

     

    2024

     

    2023

    

     

     

     

     

    Assets:

     

     

     

     

    Investments, at fair value:

     

     

     

     

    Chemed Corporation common stock

    $

    26,320,216 

    $

    31,269,864 

    Mutual funds

     

    320,030,696 

     

    295,948,053 

    Collective trust fund

     

    12,373,763 

     

    12,099,224 

    Total investments

     

    358,724,675 

     

    339,317,141 

    Receivables:

     

     

     

     

    Notes receivable from participants

     

    8,889,013 

     

    8,317,212 

    Employer contributions

     

    3,439,701 

     

    4,923,327 

    Accrued interest and dividends

     

    13,921 

     

    8,255 

    Total receivables

     

    12,342,635 

     

    13,248,794 

    Cash

     

    5,066 

     

    57,544 

    Total assets

     

    371,072,376 

     

    352,623,479 

    Liabilities:

     

     

     

     

    Accrued expenses

     

    4,099 

     

    5,543 

    Net assets available for benefits, at fair value

    $

    371,068,277 

    $

    352,617,936 

    

     

     

     

     

    The accompanying notes are an integral part of these financial statements

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    F-S 2

    

    

    

    

    

    

    

     

    

     


     

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Statement of Changes in Net Assets Available for Benefits

    

    

    

    

     

     

    

     

    Year Ended

    

     

    December 31,

    

     

    2024

    

     

     

    Contributions:

     

     

    Employer  

    $

    9,564,426 

    Participant 

     

    15,892,509 

    Rollovers

     

    715,589 

    

     

    26,172,524 

    

     

     

    Interest income on notes receivable from participants

     

    662,152 

    

     

     

    Investment income:

     

     

    Net realized and unrealized gain on investments

     

    14,427,235 

    Dividends and other income

     

    23,054,343 

    

     

    37,481,578 

    

     

     

    

     

     

    Benefits paid to participants

     

    (45,670,412)

    Administrative expenses

     

    (195,501)

    

     

    (45,865,913)

    

     

     

    Increase in net assets

     

    18,450,341 

    

     

     

    Net assets available for benefits:

     

     

    Beginning of year

     

    352,617,936 

    End of year

    $

    371,068,277 

    

     

     

    The accompanying notes are an integral part of these financial statements

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    F-S 3

    

     

    

    


     

    Chemed/Roto-Rooter

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    1.

    General Description of the Plan

    

    Overview and Eligibility

    Chemed Corporation, as the Plan Administrator, adopted the Chemed/Roto-Rooter Savings & Retirement Plan (the "Plan"). The Plan is a defined contribution plan available to all full-time employees of participating units of Chemed Corporation (the "Company"), except those covered by collective bargaining agreements, who have completed at least 500 hours of service in any six months of continuous service. The following summary provides an overview of major Plan provisions and is provided for general informational purposes. Participants should refer to the Plan document for more complete information and a full description of the Plan provisions and qualifications. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended ("ERISA").

    

    Contributions

    Employee contributions may be made from before-tax earnings, which has the effect of reducing current taxable earnings for federal income tax purposes, and/or after tax earnings. In any Plan year, an employee may contribute up to a maximum of 85% of his or her included compensation, as defined, or the maximum allowed by the Internal Revenue Code, as amended ("IRC"), whichever is less ("Basic Contribution"). For the Plan year 2024, the IRC limit on before-tax contributions was $23,000. In addition, eligible employees who have attained age 50 prior to the close of the Plan year are eligible to make a catch-up contribution of $7,500. Employee contributions are made through payroll deductions. The Company, on a participating unit basis, may elect to make contributions ("Qualified Matching Contribution") to the Plan on the first 6% of employees’ basic contribution. The Company may also elect to make discretionary contributions (“Qualified Nonelective Contribution”). The Company made discretionary contributions of $4,868,290 and $6,263,262 for the years ended December 31, 2024 and 2023, respectively.

    

    The Plan limits covered compensation for purposes of determining Basic and Matching Contributions to $345,000 for the Plan year ended December 31, 2024. All contributions are subject to limitations imposed by the IRC and ERISA.

    

    Participant Accounts

    Individual participant accounts are maintained for each Plan participant. Each participant’s account is credited with the participant’s contributions, the Company match if applicable, an allocation of Plan earnings, and charged with withdrawals and an allocation of Plan losses and administrative expenses. Allocations are based on participant earnings or account balances, as defined. The Plan benefit to which a participant is entitled is the benefit that can be provided from the participant’s account.

    

    Vesting and Forfeitures

    Participants are immediately vested in their Basic Contributions and any earnings or losses thereon. Vesting in the employer’s Matching Contributions occurs in annual 20% increments after two years of service and participants are fully vested after six years of service. Additionally, all participants of the Plan are fully vested in employer contributions upon normal retirement, death or total permanent disability incurred while employed. Participants who forfeit amounts under the Plan are permitted to restore the amount of such forfeiture by paying the Plan, subject to certain limitations, the entire withdrawn amount which gave rise to the forfeiture. Forfeitures are not permitted to be restored to the participants’ accounts after the occurrence of five consecutive one year breaks-in-service. Company may elect to use forfeitures to pay Plan administrative expenses or to reduce Qualified Nonelective Contributions and Qualified Matching Contributions.

    

    At December 31, 2024 and 2023, the forfeited account totaled $1,428,589 and $1,339,935, respectively, which was used to reduce the year end employer contributions receivable.

    

    

    F-S 4


     

    

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    

    Investment Options

    

    Investment of employee contributions is made in accordance with employee elections and stipulated Plan provisions. Beginning January 1, 1999, the Plan appointed Merrill Lynch, who was subsequently acquired by Bank of America, N.A., as trustee and currently offers participants the ability to invest contribution amounts in various mutual fund options, a stable value collective trust fund and Chemed Corporation stock. Purchases of Chemed Corporation stock are made by the Plan’s trustee on the open market. Investment in Chemed Corporation stock is limited to 20% of a participant’s total account balance. Employer contributions are invested in the same manner and allocation as the employee contributions. The Plan allows participants to transfer funds among the various investment options.

    

    Notes Receivable from Participants

    

    Participants may borrow from their vested account balance a minimum of $500 up to a maximum of 50% of the vested account balance with a maximum limit of $50,000. Loan terms range from 1 to 5 years or up to 10 years if the proceeds of the loan are used for the purchase of the participant’s primary residence. Loans are secured by the balance in the Participant’s account and bear interest at the prime rate plus 1%. Participants may not have more than two loans outstanding at any one time. Principal and interest payments are payable ratably through direct payroll deductions. Loans are in default when any scheduled payment remains unpaid beyond the last day of the calendar quarter following the calendar quarter in which the participant missed a scheduled payment. Also, a loan is in default if the participant or a representative makes a false statement to the Plan.

    

    Payment of Benefits

    

    Upon termination of service with the Company, participants are entitled to a lump sum distribution of the vested portion of their account balance. Upon retirement or if a participant becomes totally and permanently disabled or dies, the participant or their beneficiary is entitled to their entire account balance. Retired and terminated Participants who have an account balance in excess of $5,000 may elect various forms of deferred distribution.

    

    Withdrawals

    

    The Plan allows withdrawals of after-tax, rollover and vested employer matching contributions while an active employee. The Plan also allows for a "financial hardship" withdrawal of before-tax contributions for participants under age 59 ½ years in cases of demonstrated "financial hardship", as defined by the Plan document.

    

    

    Plan Termination

    

    The Company anticipates that the Plan will continue without interruption but reserves the right to discontinue the Plan subject to the provisions of ERISA and the IRC. In the event that the Plan is terminated, the participants shall be fully vested in the current market value of amounts credited to their accounts at the date of termination.

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    F-S 5


     

    

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    

    2.

    Summary of Significant Accounting Policies

    

    Investment valuation

    

    Investments of the Plan are valued at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 5.

    

    Notes receivable from participants

    

    Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Delinquent participant loans are reclassified as distributions based upon the terms of the Plan document. No allowance for credit losses has been recorded as of December 31, 2024 or 2023.

    

    Investment income

    

    Dividend income is recorded on the ex-dividend date. Interest earned on investments is recorded on the accrual basis.

    

    Payment of benefits

    

    Benefits are recorded when paid.

    

    Expenses of the Plan

    

    All expenses incurred in the administration of the Plan are paid by the Plan except for audit and legal expenses which are paid by the Company.

    

    Basis of accounting

    

    The financial statements of the Plan are prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America ("U. S. GAAP").

    

    Use of estimates

    

    The preparation of financial statements in conformity with U. S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of changes in net assets available for benefits during the reporting period. Actual results could differ from those estimates.

    

    Concentrations, risks and uncertainties

    

    The Plan has a significant concentration of investment in Chemed Corporation stock. A change in the value of this stock could cause the value of the Plan’s net assets to change significantly due to this concentration.

    

    The Plan provides for various investment options in a number of funds which include stocks, bonds, fixed income securities, mutual funds and other investment securities. Certain investments are exposed to risks such as changes in interest rates, fluctuations in market conditions and credit risk. The level of risk associated with certain investment securities and uncertainty related to changes in value of these securities could materially affect participant account balances and amounts reported in the financial statements and accompanying notes.

    

    

    

    

    

    

    

    

    

    

    F-S 6

    

    

    

    

    


     

    Chemed/Roto-Rooter

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    3. Tax Status

    

    The Internal Revenue Service ("IRS") has determined and informed the Company by a letter dated April 3, 2018, that the Plan and related trust are designed in accordance with applicable sections of the IRC. Although the Plan has been amended since receiving the determination letter, the Plan’s administrator believes that the Plan is designed and is currently being operated in compliance with the applicable sections of the IRC. The related trust is exempt from federal income tax under section 501(a) of the IRC.

    

    The Plan administrator believes it is no longer subject to income tax examinations for years prior to 2021.

    

    4. Reconciliation of Financial Statements to Form 5500

    

    The following is a reconciliation of the net assets available for benefits per the financial statements at December 31, 2024 and 2023 to Form 5500.

    

    

     

     

     

     

    

     

    December 31,

    

     

    2024

     

    2023

    

     

     

     

     

    

     

     

     

     

    Net assets available for benefits per the financial statements

    $

    371,068,277 

    $

    352,617,936 

    Amounts allocated to withdrawing participants

     

     -

     

    (122,562)

    Net assets available for benefits per the Form 5500

    $

    371,068,277 

    $

    352,495,374 

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    F-S 7


     

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    The following is a reconciliation of changes in net assets per the financial statements at December 31, 2024 to Form 5500.

    

    

     

     

    

     

    December 31,

    

     

    2024

    

     

     

    

     

     

    Increase in net assets per the financial statements

    $

    18,450,341 

    Less: Change in amounts allocated to withdrawing participants

     

    122,562 

    Net gain per Form 5500

     

    18,572,903 

    

    Amounts allocated to withdrawing participants are recorded on the Form 5500 for benefit claims that have been requested prior to December 31, but are not yet paid as of year-end.

    

    5. Fair Value Measurements

    

    Fair value is defined as the price that will be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is based on a three-level hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

    

    Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.

    

    Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in inactive markets; inputs other than quoted prices that are observable for the asset or liability; inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

    

    Level 3 – Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

    

    The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

    

    Following is a description of the valuation methodologies used for assets measured at fair value:

    

    Mutual funds – Valued using prices quoted on active markets at the measurement date.

    

    Common stock – Valued at the closing price reported on the New York Stock Exchange on which the security is traded.

    

    

    

    F-S 8


     

    Chemed/Roto-Rooter

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    Collective trust fund – Valued at the net asset value (“NAV”) of units of a bank collective trust. The NAV, as provided by the trustee, is used as a practical expedient to estimate fair value. The NAV is based on the fair value of the underlying investments held by the fund less its liabilities. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV. Participant transactions (purchases and sales) may occur daily. Were the Plan to initiate a full redemption of the collective trust, the investment adviser reserves the right to temporarily delay withdrawal from the trust in order to ensure that securities liquidations will be carried out in an orderly business manner.

    

    The following table sets forth by level, within the fair value hierarchy, the Plan’s assets at fair value:

    

    

     

     

     

     

     

     

     

     

     

     

     

    

     

     

     

    December 31, 2024

    

     

    Investments (at fair value)

     

     

    Level 1

     

     

    Level 2

     

     

    Level 3

    

     

     

     

     

     

     

     

     

     

     

     

    Common stock

    $

    26,320,216 

     

    $

    26,320,216 

     

    $

     -

     

    $

     -

    Mutual funds

     

    320,030,696 

     

     

    320,030,696 

     

     

     -

     

     

     -

    Total

     

     

     

    $

    346,350,912 

     

    $

     -

     

    $

     -

    

     

     

     

     

     

     

     

     

     

     

     

    Investments measured at NAV:

     

     

     

     

     

     

     

     

     

     

     

    Collective trust fund

     

    12,373,763 

     

     

     

     

     

     

     

     

     

    Total investments at fair value

    $

    358,724,675 

     

     

     

     

     

     

     

     

     

    

     

     

     

     

     

     

     

     

     

     

     

    

     

     

     

     

     

     

     

     

     

     

     

    

     

     

     

     

     

     

     

     

     

     

     

    

     

     

     

    December 31, 2023

    

     

    Investments (at fair value)

     

     

    Level 1

     

     

    Level 2

     

     

    Level 3

    

     

     

     

     

     

     

     

     

     

     

     

    Common stock

    $

    31,269,864 

     

    $

    31,269,864 

     

    $

     -

     

    $

     -

    Mutual funds

     

    295,948,053 

     

     

    295,948,053 

     

     

     -

     

     

     -

    Total

     

     

     

    $

    327,217,917 

     

    $

     -

     

    $

     -

    

     

     

     

     

     

     

     

     

     

     

     

    Investments measured at NAV:

     

     

     

     

     

     

     

     

     

     

     

    Collective trust fund

     

    12,099,224 

     

     

     

     

     

     

     

     

     

    Total investments at fair value

    $

    339,317,141 

     

     

     

     

     

     

     

     

     

    

    Investments in the collective trust have no holding period, and redemptions can be made daily. There are no unfunded commitments.

    

    F-S 9

    

    

    

    

    

    


     

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Notes to Financial Statements

    

    6. Party-In-Interest Transactions

    

    Certain Plan investments held during the years ended December 31, 2024 and 2023 include shares of the Company’s common stock. During 2024, approximately 1,900 shares of Chemed Corporation common stock was purchased in the amount of approximately $1,090,000 and approximately 5,700 shares of Chemed Corporation common stock was sold in the amount of approximately $3,300,000 which qualify as party-in-interest transactions.

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    F-S 10

    

    

    


     

    Chemed/Roto-Rooter

    

    Savings & Retirement Plan

    

    Form 5500 EIN 31-0791746 Plan No. 104

    Schedule H, Line 4i

    Schedule of Assets (Held At End of Year)

    December 31, 2024

    

    

    

     

     

     

     

     

     

     

    (a)

     

    (b)

     

    (c )

     

     

    (d)

    

     

     

     

     

     

     

    Current

    

     

    Identity of issue

     

    Description of investment

     

     

    Value

    

     

     

     

     

     

     

     

    

     

    Chemed Corporation common stock

     

     

     

     

     

    *

     

    Chemed Corporation 

     

    Common Stock

     

    $

    26,320,216 

    

     

     

     

     

     

     

     

    

     

    Mutual funds

     

     

     

     

     

    

     

    iShares

     

    S&P 500 Index Fund

     

     

    57,418,955 

    

     

    MFS

     

    International Intrinsic Value Fund

     

     

    48,552,733 

    

     

    T Rowe Price

     

    Blue Chip Growth Fund

     

     

    39,670,469 

    

     

    Victory Sycamore

     

    Established Value Fund

     

     

    18,545,980 

    

     

    JP Morgan

     

    Core Bond Fund

     

     

    27,430,857 

    

     

    Vanguard

     

    Federal Money Market Fund

     

     

    22,213,294 

    

     

    BlackRock

     

    Equity Dividend Fund

     

     

    18,400,333 

    

     

    American

     

    Balanced Fund

     

     

    26,883,816 

    

     

    Principal

     

    Mid Cap Growth

     

     

    21,010,847 

    

     

    Columbia

     

    Small Cap Value Fund

     

     

    8,210,469 

    

     

    Wells Fargo

     

    Short Duration Government Bond Fund

     

     

    9,514,062 

    

     

    PIMCO

     

    Real Return Fund

     

     

    7,406,607 

    

     

    Invesco

     

    International Small-Mid Company Fund

     

     

    4,704,886 

    

     

    Vanguard

     

    Explorer Fund

     

     

    10,067,388 

    

     

    Total mutual funds

     

     

     

     

    320,030,696 

    

     

     

     

     

     

     

     

    

     

    Collective trust fund

     

     

     

     

     

    

     

    Invesco

     

    Stable Value Retirement Fund

     

     

    12,373,763 

    

     

     

     

     

     

     

     

    

     

    Notes receivable from participants

     

     

     

     

     

    *

     

    Loan Fund

     

    Loans to Participants, at rates ranging from 4.25% to 9.50%

     

     

    8,889,013 

    

     

     

     

     

     

     

     

    

     

     

     

    Total

     

    $

    367,613,688 

    

     

     

     

     

     

     

     

    

     

    * Denotes party in interest.

     

     

     

     

     

    

    

    

    

    

    F-S 11

    


    Get the next $CHE alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Walsh George J Iii was granted 277 units of Capital Stock, increasing direct ownership by 9% to 3,323 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:42:26 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mount John Meredith Jr. was granted 277 units of Capital Stock, increasing direct ownership by 42% to 930 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:33:04 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mccarthy Eileen P was granted 277 units of Capital Stock, increasing direct ownership by 48% to 855 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:28:19 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    SEC Filings

    See more
    • Chemed Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CHEMED CORP (0000019584) (Filer)

      6/27/25 4:30:14 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form 11-K filed by Chemed Corp

      11-K - CHEMED CORP (0000019584) (Filer)

      6/27/25 10:00:20 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 POS filed by Chemed Corp

      S-8 POS - CHEMED CORP (0000019584) (Filer)

      5/22/25 2:31:01 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemed To Report Second-Quarter 2025 Earnings July 29, 2025

      Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarter

      6/27/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of

      5/14/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      12/30/24 11:10:35 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    See more
    • VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

      VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

      3/13/24 9:00:00 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

      Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

      12/18/23 1:20:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Retirement of David P. Williams

      Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin

      11/3/23 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Financials

    Live finance-specific insights

    See more
    • Chemed To Report Second-Quarter 2025 Earnings July 29, 2025

      Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarter

      6/27/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Reports First-Quarter 2025 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

      4/23/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/13/24 5:01:01 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/23 11:12:43 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/22 3:33:36 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously

      3/4/22 8:31:07 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $609.00 from $604.00 previously

      7/29/21 10:52:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Oppenheimer reiterated coverage on Chemed with a new price target

      Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously

      3/3/21 8:11:56 AM ET
      $CHE
      Medical/Nursing Services
      Health Care